Cost Effectiveness of Rivaroxaban For Stroke Prevention in Atrial Fibrillation Patients For Ttr and Chads2 Score in Turkey

dc.contributor.author	Ergin, Oguzhan G.
dc.contributor.author	Kockaya, G.
dc.contributor.author	Caliskan, Z.
dc.contributor.author	Okcun, S.
dc.contributor.author	Kurnaz, M.
dc.contributor.author	Buyuktuna, N.
dc.contributor.author	Saylan, M.
dc.date.accessioned	2020-06-21T12:20:04Z
dc.date.available	2020-06-21T12:20:04Z
dc.date.issued	2019
dc.identifier.issn	1098-3015
dc.identifier.issn	1524-4733
dc.identifier.uri	https://hdl.handle.net/20.500.12712/10503
dc.description	WOS: 000503167001069	en_US
dc.description.abstract	…	en_US
dc.language.iso	eng	en_US
dc.publisher	Elsevier Science Inc	en_US
dc.rights	info:eu-repo/semantics/closedAccess	en_US
dc.title	Cost Effectiveness of Rivaroxaban For Stroke Prevention in Atrial Fibrillation Patients For Ttr and Chads2 Score in Turkey	en_US
dc.type	conferenceObject	en_US
dc.contributor.department	OMÜ	en_US
dc.identifier.volume	22	en_US
dc.identifier.startpage	S552	en_US
dc.identifier.endpage	S552	en_US
dc.relation.journal	Value in Health	en_US
dc.relation.publicationcategory	Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı	en_US

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.